Anticipated to surpass the US$ 20 Billion mark in 2019, generic oncology drugs will witness an increased demand in the coming years.
MoreAnticipated to surpass the US$ 20 Billion mark in 2019, generic oncology drugs will witness an increased demand in the
MoreThe Korean pharma market is experiencing significant growth in finished drug products, according to CPhI Korea. Over the last 12
More